Nirmatrelvir-ritonavir treatment on SARS-CoV-2 viral dynamics in high altitude habitants

• Aili Lu,
• Xuefu Zhou,
• Daoping Han,
• Lu Tang,
• Xuping Rong,
• Yulan Zheng,
• Peng Hong

Affiliations

Aili Lu

Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China; Department of Infectious Diseases, Nyingchi People's Hospital, Nyingchi, Tibet, China

Xuefu Zhou

Center for Digestive Diseases, The Seventh Affiliated Hospital, Sun Yat-sen University School of Medicine, Shenzhen, Guangdong, China; Department of Gastroenterology, Nyingchi People's Hospital, Nyingchi, Tibet, China

Daoping Han

Department of Infectious Diseases, Nyingchi People's Hospital, Nyingchi, Tibet, China

Lu Tang

Department of Research, The Seventh Affiliated Hospital, Sun Yat-sen University School of Medicine, Shenzhen, Guangdong, China

Xuping Rong

Department of Infectious Diseases, Nyingchi People's Hospital, Nyingchi, Tibet, China

Yulan Zheng

Department of Respiratory and Critical Care Medicine, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China

Peng Hong

Department of Research, The Seventh Affiliated Hospital, Sun Yat-sen University School of Medicine, Shenzhen, Guangdong, China; Division of Research and Development, US Department of Veterans Affairs New York Harbor Healthcare System, Brooklyn, NY, USA; Department of Cell Biology, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA; Corresponding author. Department of Research, The Seventh Affiliated Hospital, Sun Yat-sen University School of Medicine, Shenzhen, Guangdong, China.